Search research articles
Contact Us
Filters
Showing results (1-10 of 818) with videos related to
Page
of 82
Sort By:
The American Journal of Medicine
|
February 27, 2007
Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus
Daniel J Rader
Nature Metabolism
|
August 4, 2022
Targeting ASGR1 to lower cholesterol
Daniel J Rader
The New England Journal of Medicine
|
September 10, 2015
Lysosomal Acid Lipase Deficiency--A New Therapy for a Genetic Lipid Disease
Daniel J Rader
Clinical Cardiology
|
January 24, 2003
Therapy to reduce risk of coronary heart disease
Daniel J Rader
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 4, 2005
Gain-of-function mutations and therapeutic implications: lipoprotein lipase S447X to the rescue
Daniel J Rader
Circulation
|
October 1, 2019
Enhancing Atherosclerosis Regression in Diabetic Mice Through Apo AI (Apolipoprotein AI)
Daniel J Rader
The American Journal of Cardiology
|
December 6, 2007
Liver X receptor and farnesoid X receptor as therapeutic targets
Daniel J Rader
The American Journal of Managed Care
|
February 22, 2002
Future outlook: changing perspectives on best practice
Daniel J Rader
The American Journal of Cardiology
|
April 8, 2003
Effects of nonstatin lipid drug therapy on high-density lipoprotein metabolism
Daniel J Rader
Circulation
|
August 5, 2009
Lecithin: cholesterol acyltransferase and atherosclerosis: another high-density lipoprotein story that doesn't quite follow the script
Daniel J Rader
Page
of 82
Search research articles
Search
Showing results (1-10 of 818) with videos related to
Sort By:
Page
of 82
The American Journal of Medicine
|
February 27, 2007
Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus
Daniel J Rader
Nature Metabolism
|
August 4, 2022
Targeting ASGR1 to lower cholesterol
Daniel J Rader
The New England Journal of Medicine
|
September 10, 2015
Lysosomal Acid Lipase Deficiency--A New Therapy for a Genetic Lipid Disease
Daniel J Rader
Clinical Cardiology
|
January 24, 2003
Therapy to reduce risk of coronary heart disease
Daniel J Rader
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 4, 2005
Gain-of-function mutations and therapeutic implications: lipoprotein lipase S447X to the rescue
Daniel J Rader
Circulation
|
October 1, 2019
Enhancing Atherosclerosis Regression in Diabetic Mice Through Apo AI (Apolipoprotein AI)
Daniel J Rader
The American Journal of Cardiology
|
December 6, 2007
Liver X receptor and farnesoid X receptor as therapeutic targets
Daniel J Rader
The American Journal of Managed Care
|
February 22, 2002
Future outlook: changing perspectives on best practice
Daniel J Rader
The American Journal of Cardiology
|
April 8, 2003
Effects of nonstatin lipid drug therapy on high-density lipoprotein metabolism
Daniel J Rader
Circulation
|
August 5, 2009
Lecithin: cholesterol acyltransferase and atherosclerosis: another high-density lipoprotein story that doesn't quite follow the script
Daniel J Rader
Page
of 82